ACA (ACA)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$8.50B
EV / Sales3.01
EV / EBITDA15.07
EV / Operating Cash Flow20.54
EV / Free Cash Flow35.62

Return Metrics (TTM)

Return on Equity (ROE)8.60%
Return on Assets (ROA)4.55%
Return on Invested Capital (ROIC)6.65%
Return on Capital Employed (ROCE)7.58%

Yield Metrics

Earnings Yield3.13%
Free Cash Flow Yield3.35%

Balance Sheet Strength

Net Debt / EBITDA2.42
Current Ratio2.31
Working Capital$643.80M
Tangible Asset Value$985.80M
Net Current Asset Value-$1.12B

Working Capital Efficiency

Days Sales Outstanding53.51
Days Payables Outstanding38.42
Operating Cycle (Days)112.10
Cash Conversion Cycle73.69

Capital Allocation

CapEx / Revenue6.20%
CapEx / Operating Cash Flow42.33%
R&D / Revenue0.00%
SG&A / Revenue10.95%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin22.45%
Operating Margin11.80%
Net Profit Margin7.23%

Solvency

Debt / Equity0.58
Quick Ratio1.35
Cash Ratio0.43

Per Share

Revenue / Share$58.97
FCF / Share$3.59
PE Ratio25.02